Literature DB >> 848801

Intravenous theophylline therapy: nomogram guidelines.

W J Jusko, J R Koup, J W Vance, J J Schentag, P Kuritzky.   

Abstract

We evolved a nomogram for guiding and standardizing intravenous theophylline therapy in hospitalized patients. It provides rapid calculation of a loading dose based on body weight and previous therapy and a maintenance infusion rate related to three categories of expected metabolic activity. The guidelines were prospectively used in the treatment of 72 patients, mainly in a respiratory care unit. The nomogram was successfully used to attain near-steady-state serum concentrations in the therapeutic range of 8 to 20 mg/litre in 72% of patients, with only two patients outside of the range of 5 to 25 mg/litre. These guidelines facilitate initial theophylline dosage in older patients with liver and cardiac disease and provide a rational basis for interpreting serum concentration measurements and adjustment of drug therapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 848801     DOI: 10.7326/0003-4819-86-4-400

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  [Pharmacokinetics and pharmacodynamics of theophylline in geriatric patients with multiple diseases].

Authors:  W Mühlberg; D Platt; M Bauer; U Salzner
Journal:  Klin Wochenschr       Date:  1987-07-15

Review 3.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 4.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

5.  The relationship between clearance of theophylline and age within the adult age range.

Authors:  S H Jackson; J K Wiffen; A Johnston; C A Peverel-Cooper
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Monitoring aminophylline therapy using Jusko's dosage guidelines.

Authors:  E P Calandre; A J Perez de la Cruz; A M Morales; N P Alférez; E Moreno; G V Mata
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

7.  Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppositories.

Authors:  P Bolme; P O Edlund; M Eriksson; L Paalzow; B Winbladh
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

8.  Theophylline-induced seizures: clinical and pathophysiologic aspects.

Authors:  T Nakada; I L Kwee; A M Lerner; M P Remler
Journal:  West J Med       Date:  1983-03

9.  Theophylline pharmacokinetics in advanced age.

Authors:  E J Antal; P A Kramer; S A Mercik; D J Chapron; I R Lawson
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

10.  Aging, cigarette smoking and oral theophylline requirement.

Authors:  T Talseth; N P Boye; J Kongerud; J E Bredesen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.